Characterizing CAR Function Across Disease Indications to Enable Clinical Expansion
- Measuring CAR targeting and functional activity across diseases to understand indication-specific performance
- Comparing assay approaches assessing binding, functionality and cytotoxicity to ensure cross-indication characterization